Phenotype
|
Conditions
|
Figures
|
apoptotic process increased occurrence, abnormal
|
standard conditions
|
Fig. 3
from Tsai et al., 2012
Fig. 1
from Lu et al., 2011
|
apoptotic process occurrence, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 3
from Tsai et al., 2012
|
atrium myh6 expression amount, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 6
from Tsai et al., 2012
|
atrium myh6 expression decreased amount, abnormal
|
standard conditions
|
Fig. 6
from Tsai et al., 2012
|
atrium morphology, abnormal
|
standard conditions
|
Fig. 4
from Ghosh et al., 2017
|
atrium size, abnormal
|
standard conditions
|
Fig. 4
from Ghosh et al., 2017
|
cardiac muscle cell normal amount, normal
|
standard conditions
|
Fig. 1
from Lou et al., 2011
|
cardiac muscle cell bicellular tight junction dissociated from cardiac muscle cell bicellular tight junction, abnormal
|
standard conditions
|
Fig. 7
from Lu et al., 2011
|
cardiac muscle cell mitochondrion increased amount, abnormal
|
standard conditions
|
Fig. 7
from Lu et al., 2011
|
cardiac muscle cell mitochondrion swollen, abnormal
|
standard conditions
|
Fig. 7
from Lu et al., 2011
|
cardiac ventricle myh7 expression amount, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 6
from Tsai et al., 2012
|
cardiac ventricle myl7 expression amount, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 6
from Tsai et al., 2012
|
cardiac ventricle myh7 expression decreased amount, abnormal
|
standard conditions
|
Fig. 6
from Tsai et al., 2012
|
cardiac ventricle myl7 expression decreased amount, abnormal
|
standard conditions
|
Fig. 6
from Tsai et al., 2012
|
cardiac ventricle decreased contractility, abnormal
|
standard conditions
|
Fig. 1
from Tsai et al., 2012
|
cardiac ventricle morphology, abnormal
|
standard conditions
|
Fig. 4
from Ghosh et al., 2017
|
cardiac ventricle size, abnormal
|
standard conditions
|
Fig. 4
from Ghosh et al., 2017
|
heart decreased size, abnormal
|
standard conditions
|
Fig. 2
from Lu et al., 2008
|
heart edematous, abnormal
|
standard conditions
|
Fig. 1
from Tsai et al., 2012
|
heart malformed, abnormal
|
standard conditions
|
Fig. 1
from Pi-Roig et al., 2014
Fig. 1
from Lu et al., 2011
|
heart morphology, abnormal
|
standard conditions
|
Fig. 4
from Ghosh et al., 2017
Fig. 6
from Li et al., 2014
Fig. 1
from Tsai et al., 2012
Fig. 1,
Fig. 2,
Fig. 5
from Lu et al., 2008
Fig. 9
from Qu et al., 2008
|
heart morphology, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 6
from Li et al., 2014
|
heart morphology, normal
|
standard conditions
|
Fig. 1
from Lou et al., 2011
|
heart contraction decreased rate, abnormal
|
standard conditions
|
Fig. 4
from Ghosh et al., 2017
|
heart development disrupted, abnormal
|
standard conditions
|
Fig. 9
from Qu et al., 2008
|
heart jogging disrupted, abnormal
|
standard conditions
|
Fig. 2
from Pi-Roig et al., 2014
|
heart looping arrested, abnormal
|
standard conditions
|
Fig. 1
from Pi-Roig et al., 2014
Fig. 4
from Garrity et al., 2002
|
heart looping disrupted, abnormal
|
standard conditions
|
Fig. 1
from Pi-Roig et al., 2014
Fig. 1
from Lu et al., 2011
Fig. 6
from Ghosh et al., 2009
Fig. 1,
Fig. 2,
Fig. 5
from Lu et al., 2008
|
heart looping process quality, abnormal
|
standard conditions
|
Fig. 4
from Ghosh et al., 2017
|
heart morphogenesis process quality, normal
|
standard conditions
|
Fig. 1
from Lou et al., 2011
|
heart tube linear, abnormal
|
standard conditions
|
Fig. 4
from Garrity et al., 2002
|
myocardium disorganized, abnormal
|
standard conditions
|
Fig. 7
from Lu et al., 2011
|
myocardium myofibril disorganized, abnormal
|
standard conditions
|
Fig. 7
from Lu et al., 2011
|
paired fin absent, abnormal
|
standard conditions
|
Fig. 6
from Ghosh et al., 2017
|
paired fin decreased size, abnormal
|
standard conditions
|
Fig. 6
from Ghosh et al., 2017
|
paired fin morphology, abnormal
|
standard conditions
|
Fig. 6
from Ghosh et al., 2017
|
pectoral fin absent, abnormal
|
standard conditions
|
Fig. 4
from Garrity et al., 2002
|
pectoral fin aplastic, abnormal
|
standard conditions
|
Fig. 5
from Pi-Roig et al., 2014
Fig. 1
from Tsai et al., 2012
Fig. 6
from Ghosh et al., 2009
|
pectoral fin hypoplastic, abnormal
|
standard conditions
|
Fig. 1
from Lu et al., 2011
|
pectoral fin morphology, abnormal
|
standard conditions
|
Fig. 6
from Li et al., 2014
|
pectoral fin morphology, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 6
from Li et al., 2014
|
pectoral fin truncated, abnormal
|
standard conditions
|
Fig. 1
from Tsai et al., 2012
|
pectoral fin upturned, abnormal
|
standard conditions
|
Fig. 4
from Garrity et al., 2002
|
pectoral fin bud absent, abnormal
|
standard conditions
|
Fig. 6
from Fischer et al., 2003
|
pectoral fin development disrupted, abnormal
|
standard conditions
|
Fig. 5
from Pi-Roig et al., 2014
|
pericardium edematous, abnormal
|
standard conditions
|
Fig. 4
from Ghosh et al., 2017
Fig. 6
from Ghosh et al., 2009
Fig. 1,
Fig. 2
from Lu et al., 2008
|
somite shape, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 6
from Li et al., 2014
|
somite U-shaped, abnormal
|
standard conditions
|
Fig. 6
from Li et al., 2014
Fig. 1
from Tsai et al., 2012
|
trunk bent, abnormal
|
standard conditions
|
Fig. 1
from Tsai et al., 2012
|
trunk curled, abnormal
|
standard conditions
|
Fig. 1
from Lu et al., 2011
|
trunk decreased length, abnormal
|
standard conditions
|
Fig. 1
from Lu et al., 2011
|
whole organism cdk2 expression amount, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 5
from Tsai et al., 2012
|
whole organism badb expression amount, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 4
from Tsai et al., 2012
|
whole organism cdkn1bb expression amount, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 5
from Tsai et al., 2012
|
whole organism bcl2a expression amount, ameliorated
|
chemical treatment by injection: growth hormone
|
Fig. 4
from Tsai et al., 2012
|
whole organism ghrb expression decreased amount, abnormal
|
standard conditions
|
Fig. 2
from Tsai et al., 2012
|
whole organism akt2 expression decreased amount, abnormal
|
standard conditions
|
Fig. 2
from Tsai et al., 2012
|
whole organism ghra expression decreased amount, abnormal
|
standard conditions
|
Fig. 2
from Tsai et al., 2012
|
whole organism igf1 expression decreased amount, abnormal
|
standard conditions
|
Fig. 2
from Tsai et al., 2012
|
whole organism cdk2 expression increased amount, abnormal
|
standard conditions
|
Fig. 5
from Tsai et al., 2012
|
whole organism bcl2a expression increased amount, abnormal
|
standard conditions
|
Fig. 4
from Tsai et al., 2012
|
whole organism cdkn1bb expression increased amount, abnormal
|
standard conditions
|
Fig. 5
from Tsai et al., 2012
|
whole organism badb expression increased amount, abnormal
|
standard conditions
|
Fig. 4
from Tsai et al., 2012
|
whole organism lacks parts or has fewer parts of type pectoral fin, abnormal
|
standard conditions
|
Fig. 4
from Garrity et al., 2002
|
whole organism semi-lethal (sensu genetics), abnormal
|
standard conditions
|
Fig. 2
from Lu et al., 2008
|